1st Quarter - Report

CYSTIC FIBROSIS FOUNDATION for CYSTIC FIBROSIS FOUNDATION

Firm
Client
Income
—
Expenses
$100,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Board on the Hill and March on the Hill advocacy days, Sequestration, NIH-FDA Budget, FDA Breakthrough Designation, Prescription Drug User Fee Act Congressional follow up, International CF project, Lasker award congressional support, federal budget and appropriations, Social Security Disability Insurance eligibility changes, Medicaid cost-sharing

LobbyistCovered position, as disclosed
ERIC CHAMBERLAIN —
MARY B DWIGHT Legislative Correspondent; Legislative Assistant
JACQUELINE ERDO —
STEPHANIE KRENRICH Sr. Leg. Asst.; Leg. Asst.; Leg. Aide; Leg. Corr.
JASON RANVILLE —

Contacted: Social Security Administration (SSA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Natl Institutes of Health (NIH); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.